Variant report

Variant	esv3435142
Chromosome Location	chr1:227163129-227165127
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:10)
CpG islands
(count:427)
Chromatin interactive
region (count:3)
LncRNA
region (count:0)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

(count:10 , 50 per page) page: 1

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	CEBPB	chr1:227164458-227164488	HepG2	liver:	n/a	chr1:227164464-227164475 chr1:227164463-227164476
2	CTCF	chr1:227163680-227163830	HA-sp	spinal cord:	n/a	chr1:227163727-227163740
3	POLR2A	chr1:227163871-227164154	HepG2	liver:	n/a	n/a
4	POLR2A	chr1:227164510-227164859	HepG2	liver:	n/a	n/a
5	POLR2A	chr1:227163368-227163452	Hela-S3	cervix:	n/a	n/a
6	POLR2A	chr1:227164382-227167024	HL-60	blood:	n/a	n/a
7	POLR2A	chr1:227162246-227163144	HepG2	liver:	n/a	n/a
8	SPI1	chr1:227164580-227164898	HL-60	blood:	n/a	n/a
9	TAF1	chr1:227163733-227164159	HepG2	liver:	n/a	n/a
10	TCF3	chr1:227163728-227164122	GM12878	blood:	n/a	n/a

(count:427 , 50 per page) page: 1 2 3 4 5 6 7 ... 9

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr1:227163884-227163934	NHBE	bronchial:	n/a
2	chr1:227164132-227164182	HCT-116	colon:	n/a
3	chr1:227163427-227163477	PANC-1	pancreas:	n/a
4	chr1:227163700-227163750	MCF-7	breast:	n/a
5	chr1:227163884-227163934	HCM	heart:	n/a
6	chr1:227163775-227163825	Caco-2	colon:	n/a
7	chr1:227164132-227164182	HEK293	kidney:	embryo
8	chr1:227164459-227164509	HRCEpiC	kidney:	n/a
9	chr1:227163700-227163750	NT2-D1	testis:	n/a
10	chr1:227164459-227164509	SKMC	muscle:	n/a
11	chr1:227163427-227163477	MCF10A-Er-Src	breast:	n/a
12	chr1:227163427-227163477	HRE	kidney:	n/a
13	chr1:227164132-227164182	HAEpiC	amniotic membrane:	n/a
14	chr1:227163775-227163825	HCT-116	colon:	n/a
15	chr1:227163996-227164046	MCF10A-Er-Src	breast:	n/a
16	chr1:227163996-227164046	SAEC	small airway:	n/a
17	chr1:227164459-227164509	GM06990	blood:	n/a
18	chr1:227163884-227163934	GM12891	blood:	n/a
19	chr1:227164132-227164182	Hela-S3	cervix:	n/a
20	chr1:227163700-227163750	AG09309	skin:	n/a
21	chr1:227164132-227164182	SKMC	muscle:	n/a
22	chr1:227164132-227164182	HL-60	blood:	n/a
23	chr1:227163427-227163477	ECC-1	luminal epithelium:	n/a
24	chr1:227163996-227164046	HRE	kidney:	n/a
25	chr1:227163996-227164046	BJ	skin:	n/a
26	chr1:227163427-227163477	Hela-S3	cervix:	n/a
27	chr1:227163884-227163934	GM06990	blood:	n/a
28	chr1:227163700-227163750	HCM	heart:	n/a
29	chr1:227163996-227164046	A549	lung:	n/a
30	chr1:227164132-227164182	GM12892	blood:	n/a
31	chr1:227163775-227163825	HRCEpiC	kidney:	n/a
32	chr1:227163700-227163750	GM19239	blood:	n/a
33	chr1:227163700-227163750	Hepatocyte	liver:	n/a
34	chr1:227163996-227164046	HCM	heart:	n/a
35	chr1:227163427-227163477	LNCaP	prostate:	n/a
36	chr1:227163996-227164046	HNPCEpiC	eye:	n/a
37	chr1:227163700-227163750	ovcar-3	ovarian:	n/a
38	chr1:227163884-227163934	Hepatocyte	liver:	n/a
39	chr1:227164132-227164182	T-47D	breast:	n/a
40	chr1:227163775-227163825	HCPEpiC	choroid plexus:	n/a
41	chr1:227163884-227163934	AG04449	skin:	fetal
42	chr1:227164459-227164509	NHBE	bronchial:	n/a
43	chr1:227163996-227164046	HCF	heart:	n/a
44	chr1:227163700-227163750	T-47D	breast:	n/a
45	chr1:227163700-227163750	MCF10A-Er-Src	breast:	n/a
46	chr1:227163700-227163750	ProgFib	skin:	n/a
47	chr1:227163884-227163934	GM19239	blood:	n/a
48	chr1:227164459-227164509	AoSMC	blood vessel:	n/a
49	chr1:227163700-227163750	GM12892	blood:	n/a
50	chr1:227163775-227163825	AG10803	skin:	n/a

(count:3 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type
1	chr1:227129763..227131276-chr1:227162634..227164932,2	K562	blood:
2	chr1:227158478..227161173-chr1:227162691..227164672,2	K562	blood:
3	chr1:227127948..227129868-chr1:227162930..227165927,2	MCF-7	breast:

No data

Variant related genes	Relation type
ADCK3	TF binding region
ADCK3	CpG island
ENSG00000163050	chromatin interactions

Extended variants
information (count: 90 )
Associated
traits (count: 90 )

Variant overlapped rSNPs/rCNVs (count:90 , 50 per page) page: 1 2

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs533237667	chr1:227163172-227163173	Weak transcription Enhancers Strong transcription Genic enhancers Flanking Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
2	rs113758646	chr1:227163175-227163176	Weak transcription Enhancers Strong transcription Genic enhancers Flanking Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
3	rs369590856	chr1:227163227-227163228	Weak transcription Enhancers Strong transcription Active TSS Flanking Active TSS Genic enhancers	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
4	rs527537463	chr1:227163244-227163245	Weak transcription Enhancers Strong transcription Active TSS Flanking Active TSS Genic enhancers	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
5	rs373146310	chr1:227163349-227163350	Weak transcription Enhancers Strong transcription Active TSS Flanking Active TSS Genic enhancers	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
6	rs548985849	chr1:227163360-227163361	Weak transcription Enhancers Strong transcription Active TSS Flanking Active TSS Genic enhancers	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
7	rs76458154	chr1:227163378-227163379	Weak transcription Enhancers Strong transcription Active TSS Flanking Active TSS Genic enhancers	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
8	rs567117826	chr1:227163435-227163436	Weak transcription Enhancers Strong transcription Flanking Active TSS Active TSS Genic enhancers	TF binding region CpG island Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
9	rs537833472	chr1:227163442-227163443	Weak transcription Enhancers Strong transcription Flanking Active TSS Active TSS Genic enhancers	TF binding region CpG island Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
10	rs556015220	chr1:227163446-227163447	Weak transcription Enhancers Strong transcription Flanking Active TSS Active TSS Genic enhancers	TF binding region CpG island Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
11	rs571319017	chr1:227163450-227163451	Weak transcription Enhancers Strong transcription Flanking Active TSS Active TSS Genic enhancers	TF binding region CpG island Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
12	rs539687436	chr1:227163471-227163472	Weak transcription Enhancers Strong transcription Flanking Active TSS Active TSS Genic enhancers	CpG island Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
13	rs557892380	chr1:227163473-227163474	Weak transcription Enhancers Strong transcription Flanking Active TSS Active TSS Genic enhancers	CpG island Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
14	rs528795681	chr1:227163532-227163533	Weak transcription Enhancers Strong transcription Flanking Active TSS Active TSS Genic enhancers	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
15	rs540489226	chr1:227163533-227163534	Weak transcription Enhancers Strong transcription Flanking Active TSS Active TSS Genic enhancers	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
16	rs145979753	chr1:227163541-227163542	Weak transcription Enhancers Strong transcription Flanking Active TSS Active TSS Genic enhancers	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
17	rs551312609	chr1:227163549-227163550	Weak transcription Enhancers Strong transcription Flanking Active TSS Active TSS Genic enhancers	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
18	rs573976659	chr1:227163556-227163557	Weak transcription Enhancers Strong transcription Flanking Active TSS Active TSS Genic enhancers	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
19	rs138572740	chr1:227163687-227163688	Weak transcription Enhancers Strong transcription Flanking Active TSS Genic enhancers	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
20	rs4653780	chr1:227163717-227163718	Weak transcription Enhancers Strong transcription Flanking Active TSS Genic enhancers	TF binding region CpG island Chromatin interactive region	2 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
21	rs545226664	chr1:227163733-227163734	Weak transcription Enhancers Strong transcription Flanking Active TSS Genic enhancers	TF binding region CpG island Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
22	rs4570388	chr1:227163757-227163758	Weak transcription Enhancers Strong transcription Flanking Active TSS Genic enhancers	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
23	rs527601677	chr1:227163758-227163759	Weak transcription Enhancers Strong transcription Flanking Active TSS Genic enhancers	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
24	rs549043433	chr1:227163780-227163781	Weak transcription Enhancers Strong transcription Flanking Active TSS Genic enhancers	TF binding region CpG island Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
25	rs201956338	chr1:227163805-227163806	Weak transcription Active TSS Enhancers Strong transcription Flanking Active TSS Genic enhancers	TF binding region CpG island Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
26	rs2989948	chr1:227163822-227163823	Weak transcription Active TSS Enhancers Strong transcription Flanking Active TSS Genic enhancers	TF binding region CpG island Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
27	rs2989947	chr1:227163828-227163829	Weak transcription Active TSS Enhancers Strong transcription Flanking Active TSS Genic enhancers	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
28	rs372505597	chr1:227163853-227163854	Weak transcription Active TSS Enhancers Strong transcription Flanking Active TSS Genic enhancers	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
29	rs111545649	chr1:227163870-227163871	Weak transcription Active TSS Enhancers Strong transcription Flanking Active TSS Genic enhancers	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
30	rs111475239	chr1:227163876-227163877	Weak transcription Active TSS Enhancers Strong transcription Flanking Active TSS Genic enhancers	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
31	rs374591374	chr1:227163884-227163885	Weak transcription Active TSS Enhancers Strong transcription Flanking Active TSS Genic enhancers	TF binding region CpG island Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
32	rs377653288	chr1:227163905-227163906	Weak transcription Active TSS Enhancers Strong transcription Flanking Active TSS Genic enhancers	TF binding region CpG island Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
33	rs34107985	chr1:227163918-227163919	Weak transcription Active TSS Enhancers Strong transcription Flanking Active TSS Genic enhancers	TF binding region CpG island Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
34	rs111263379	chr1:227163924-227163925	Weak transcription Active TSS Enhancers Strong transcription Flanking Active TSS Genic enhancers	TF binding region CpG island Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
35	rs371004162	chr1:227163932-227163933	Weak transcription Active TSS Enhancers Strong transcription Flanking Active TSS Genic enhancers	TF binding region CpG island Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
36	rs550648776	chr1:227163956-227163957	Weak transcription Active TSS Enhancers Strong transcription Flanking Active TSS Genic enhancers	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
37	rs567532397	chr1:227163957-227163958	Weak transcription Active TSS Enhancers Strong transcription Flanking Active TSS Genic enhancers	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
38	rs374402094	chr1:227163966-227163967	Weak transcription Active TSS Enhancers Strong transcription Flanking Active TSS Genic enhancers	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
39	rs531257095	chr1:227163968-227163969	Weak transcription Active TSS Enhancers Strong transcription Flanking Active TSS Genic enhancers	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
40	rs544252664	chr1:227163981-227163982	Weak transcription Active TSS Enhancers Strong transcription Flanking Active TSS Genic enhancers	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
41	rs370484835	chr1:227163988-227163989	Weak transcription Active TSS Enhancers Strong transcription Flanking Active TSS Genic enhancers	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
42	rs118075665	chr1:227164005-227164006	Weak transcription Active TSS Enhancers Strong transcription Genic enhancers Flanking Active TSS	TF binding region CpG island Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
43	rs190484237	chr1:227164022-227164023	Weak transcription Active TSS Enhancers Strong transcription Genic enhancers Flanking Active TSS	TF binding region CpG island Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
44	rs367594809	chr1:227164036-227164037	Weak transcription Active TSS Enhancers Strong transcription Genic enhancers Flanking Active TSS	TF binding region CpG island Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
45	rs371737308	chr1:227164075-227164076	Weak transcription Active TSS Enhancers Strong transcription Genic enhancers Flanking Active TSS	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
46	rs112426397	chr1:227164083-227164084	Weak transcription Active TSS Enhancers Strong transcription Genic enhancers Flanking Active TSS	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
47	rs144395746	chr1:227164112-227164113	Weak transcription Active TSS Enhancers Strong transcription Genic enhancers Flanking Active TSS	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
48	rs538316417	chr1:227164128-227164129	Weak transcription Active TSS Enhancers Strong transcription Genic enhancers Flanking Active TSS	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
49	rs375980506	chr1:227164132-227164133	Weak transcription Active TSS Enhancers Strong transcription Genic enhancers Flanking Active TSS	TF binding region CpG island Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
50	rs566756266	chr1:227164148-227164149	Weak transcription Active TSS Enhancers Strong transcription Genic enhancers Flanking Active TSS	TF binding region CpG island Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a

Variant related diseases (count:90)

Disease	PMID	Source
Esophageal squamous carcinoma	21637470	CNVD
HIV/AIDS	22032296	CNVD
Schizophrenia	19415332	CNVD
Autism	22495311	CNVD
Melanoma	18172304	CNVD
Rett syndrome	21593744	CNVD
Medulloblastoma	21979893	CNVD
Cancer	20164919	CNVD
Wilms tumour	21544195	CNVD
Breast cancer	17133270	CNVD
Non-small cell lung cancer	21044232	CNVD
Cervical cancer	21063398	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Astrocytoma	17387387	CNVD
Breast cancer	20632083	CNVD
Endometrial cancer	22040021	CNVD
Ewing''s sarcoma	21437220	CNVD
Gastrointestinal stromal cancer	20470368	CNVD
Glioblastoma multiforme	19960244	CNVD
Glioblastoma multiforme	21080181	CNVD
Hepatocellular carcinoma	22174799	CNVD
Medulloblastoma	21292688	CNVD
Phyllodes tumor	17334353	CNVD
Breast cancer	21264507	CNVD
Liposarcoma	21253554	CNVD
Multiple myeloma	21628407	CNVD
Cancer	16751803	CNVD
Prostate cancer	16705090	CNVD
Neuroblastoma	19435921	CNVD
Breast cancer	17850661	CNVD
Breast cancer	16461572	CNVD
Intracranial tumor	16823260	CNVD
Medulloblastoma	18056178	CNVD
Monoclonal gammopathy of undetermined significance	17077331	CNVD
Primary mediastinal b-cell lymphoma	17728785	CNVD
Colorectal cancer	16272173	CNVD
Acute lymphoblastic leukemia	21098271	CNVD
Breast cancer	17603634	CNVD
Neuroblastoma	21899760	CNVD
Breast cancer	21858162	CNVD
Non-small cell lung cancer	21385341	CNVD
Acute lymphoblastic leukemia	21980252	CNVD
Breast cancer	16608533	CNVD
Ewing''s sarcoma	22429812	CNVD
Acute promyelocytic leukemia	19109227	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Breast cancer	17001317	CNVD
Acute myeloid leukemia	21251322	CNVD
Multiple myeloma	17550852	CNVD
Prostate cancer	18632612	CNVD
Acute myeloid leukemia	20729466	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Testicular germ cell tumor	18059402	CNVD
Ependymoma	18628472	CNVD
Leukemia	18628472	CNVD
Neuroblastoma	18923191	CNVD
Acute lymphoblastic leukemia	19100363	CNVD
Breast cancer	21509527	CNVD
Endometrioid adenocarcinoma	16974079	CNVD
Urothelial carcinoma	21177765	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Chordoma	18071362	CNVD
T-cell lymphomas	19863542	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Hepatocellular carcinoma	18803288	CNVD
Urothelial tumor	18831757	CNVD
Lung cancer	18438408	CNVD
Medulloblastoma	16783165	CNVD
Basal cell lymphoma	17170743	CNVD
Mental retardation	19951919	CNVD
Non-syndromic sensorineural hearing loss	17873649	CNVD
Basal cell lymphoma	17053054	CNVD
Autism	14699429	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Fumarase deficiency	21572526	CNVD
Autism	17483303	CNVD
Kartagener syndrome	16639409	CNVD
Congenital abnormalities	21549014	CNVD
Developmental delay	21549014	CNVD
Mental retardation	21549014	CNVD
small cell lung cancer	20016488	CNVD
Glioblastoma multiforme	21138945	CNVD
Ovarian clear cell carcinoma	21343371	CNVD
Cancer	20164920	CNVD
Cancer	17060936	CNVD
Myelofibrosis	22110671	CNVD
abnormal development	18461090	CNVD
Breast cancer	21364760	CNVD
Acute lymphoblastic leukemia	22237106	CNVD

Chromatin state (count:214 , 50 per page) page: 1 2 3 4 5

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr1:227131000-227171800	Weak transcription	Primary T killer memory cells from peripheral blood	blood
2	chr1:227147000-227177000	Weak transcription	Primary T killer naive cells fromperipheralblood	blood
3	chr1:227148600-227180800	Weak transcription	Pancreatic Islets	Pancreatic Islet
4	chr1:227154200-227164200	Weak transcription	Primary T cells effector/memory enriched fromperipheralblood	blood
5	chr1:227154400-227165800	Weak transcription	H1 Cell Line	embryonic stem cell
6	chr1:227154400-227294200	Weak transcription	Hela-S3	cervix
7	chr1:227154600-227163200	Weak transcription	Fetal Thymus	thymus
8	chr1:227154800-227176800	Weak transcription	Primary T helper naive cells from peripheral blood	blood
9	chr1:227158400-227164600	Weak transcription	Dnd41	blood
10	chr1:227158400-227173200	Weak transcription	K562	blood
11	chr1:227158400-227174600	Weak transcription	HUES48 Cell Line	embryonic stem cell
12	chr1:227158400-227183000	Weak transcription	ES-I3 Cell Line	embryonic stem cell
13	chr1:227159000-227175800	Strong transcription	Primary hematopoietic stem cells short term culture	blood
14	chr1:227159800-227163800	Strong transcription	Primary T regulatory cells fromperipheralblood	blood
15	chr1:227159800-227165800	Weak transcription	Primary hematopoietic stem cells	blood
16	chr1:227159800-227174000	Weak transcription	HUES64 Cell Line	embryonic stem cell
17	chr1:227160000-227173600	Weak transcription	A549	lung
18	chr1:227160000-227174400	Weak transcription	iPS-20b Cell Line	embryonic stem cell
19	chr1:227160000-227174400	Strong transcription	Primary hematopoietic stem cells G-CSF-mobilized Female	--
20	chr1:227160000-227174800	Strong transcription	Primary hematopoietic stem cells G-CSF-mobilized Male	--
21	chr1:227160000-227177200	Weak transcription	GM12878-XiMat	blood
22	chr1:227160200-227165200	Weak transcription	Foreskin Melanocyte Primary Cells skin03	Skin
23	chr1:227160200-227165200	Enhancers	Liver	Liver
24	chr1:227160400-227163200	Strong transcription	Monocytes-CD14+_RO01746	blood
25	chr1:227160400-227164600	Enhancers	Right Atrium	heart
26	chr1:227160400-227164800	Weak transcription	Primary T helper 17 cells PMA-I stimulated	--
27	chr1:227160400-227165200	Weak transcription	Primary Natural Killer cells fromperipheralblood	blood
28	chr1:227160600-227163200	Flanking Active TSS	Skeletal Muscle Female	skeletal muscle
29	chr1:227160600-227163200	Enhancers	Small Intestine	intestine
30	chr1:227160600-227163400	Enhancers	Fetal Heart	heart
31	chr1:227160600-227163400	Flanking Active TSS	Stomach Smooth Muscle	stomach
32	chr1:227160600-227163800	Enhancers	Brain Angular Gyrus	brain
33	chr1:227160600-227163800	Enhancers	Fetal Muscle Trunk	muscle
34	chr1:227160600-227163800	Enhancers	Fetal Muscle Leg	muscle
35	chr1:227160600-227163800	Enhancers	Ovary	ovary
36	chr1:227160600-227163800	Flanking Active TSS	Skeletal Muscle Male	skeletal muscle
37	chr1:227160600-227165000	Enhancers	Right Ventricle	heart
38	chr1:227160600-227165400	Enhancers	Left Ventricle	heart
39	chr1:227160600-227165800	Enhancers	Psoas Muscle	Psoas
40	chr1:227160600-227175600	Strong transcription	Primary mononuclear cells fromperipheralblood	Blood
41	chr1:227160800-227163200	Enhancers	IMR90 fetal lung fibroblasts Cell Line	lung
42	chr1:227160800-227163200	Enhancers	Breast Myoepithelial Primary Cells	Breast
43	chr1:227160800-227163400	Enhancers	Fetal Adrenal Gland	Adrenal Gland
44	chr1:227160800-227163600	Enhancers	ES-UCSF4 Cell Line	embryonic stem cell
45	chr1:227160800-227163800	Enhancers	Brain Dorsolateral Prefrontal Cortex	brain
46	chr1:227160800-227163800	Enhancers	Fetal Brain Male	brain
47	chr1:227160800-227164200	Weak transcription	Primary neutrophils fromperipheralblood	blood
48	chr1:227160800-227164800	Enhancers	H9 Derived Neuronal Progenitor Cultured Cells	ES cell derived
49	chr1:227160800-227164800	Enhancers	H9 Derived Neuron Cultured Cells	ES cell derived
50	chr1:227160800-227181800	Weak transcription	iPS DF 6.9 Cell Line	embryonic stem cell

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links